InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript

Group 1 - InMed Pharmaceuticals held its 2025 Annual General Meeting of Shareholders, chaired by CEO Eric Adams [1][2] - The meeting included a sworn declaration confirming that all materials were mailed to security holders as of October 22, 2025 [3]